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Abstract

This systematic review examined whether event-related potentials (ERPs) during higher cognitive
processing can detect subtle, early signs of neurodegenerative disease. Original, empirical studies
retrieved from PsycINFO and PubMed were reviewed if they analyzed patterns in cognitive ERPs
(≥150 ms post-stimulus) differentiating mild cognitive impairment (MCI), Alzheimer’s disease (AD), or

cognitively intact elders who carry AD risk through the Apolipoprotein-E ε4 allele (ε4+) from healthy
older adult controls (HC). The 100 studies meeting inclusion criteria (MCI = 47; AD = 47; ε4+ = 6)
analyzed N200, P300, N400, and occasionally, later components. While there was variability across
studies, patterns of reduced amplitude and delayed latency were apparent in pathological aging,
consistent with AD-related brain atrophy and cognitive impairment. These effects were particularly
evident in advanced disease progression (i.e., AD > MCI) and in later ERP components measured during
complex tasks. Although ERP studies in intact ε4+ elders are thus far scarce, a similar pattern of
delayed latency was notable, along with a contrasting pattern of increased amplitude, consistent with
compensatory neural activation. This limited work suggests ERPs might be able to index early neural
changes indicative of future cognitive decline in otherwise healthy elders. As ERPs are also accessible
and affordable relative to other neuroimaging methods, their addition to cognitive assessment might
substantively enhance early identification and characterization of neural dysfunction, allowing
opportunity for earlier differential diagnosis and targeting of intervention. To evaluate this possibility
there is urgent need for well-powered studies assessing late cognitive ERPs during complex tasks,
particularly in healthy elders at risk for cognitive decline.
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1. Introduction

Alzheimer’s disease (AD) is a neurodegenerative disease that is closely associated with an
accumulation of beta-amyloid plaques, neurofibrillary tangles, and brain atrophy [113]. Symptoms of
the disease include marked cognitive decline from baseline functioning in areas such as planning,
problem solving, memory, language, and orientation, as well as impairment in completing instrumental
activities of daily living [2]. Mild cognitive impairment (MCI) is considered a prodromal form of AD due
to the comparable though less severe neuropathology and cognitive decline; approximately 10 % of
those with MCI convert to AD each year [17]. Early detection is especially important in AD as its
neuropathological hallmarks may be present decades before onset of symptoms [2,9]. One primary
factor associated with risk for AD is carrying the Apolipoprotein-E (APOE) ε4 allele. Those who carry
one of two copies of the ε4 allele have a 3−4x greater than average risk of AD, while those who carry
both ε4 alleles have 10x greater risk [141].
The investigation of neural biomarkers, such as those using neuroimaging measures for AD is an
important and burgeoning field. A biomarker is a measure that offers an objective index of structural
or functional differences that can be used to predict or track a disease [134]. Although methods such
as functional magnetic resonance imaging (fMRI) dominate the literature, electroencephalography
(EEG) and event-related potentials (ERPs) hold particular promise due to their accessibility,
affordability, and superior temporal specificity compared with other neuroimaging modalities. Thus,
ERPs could be a valuable addition to cognitive assessment in identifying and tracking disease onset and
progression.
EEG is a neurophysiological methodology in which electrical activity of the brain (i.e., summed
postsynaptic potentials) is recorded via electrodes placed on the scalp. ERPs are an application of EEG

that specifically time-lock such electrophysiological activity to a stimulus or a behavioral response. The
amplitude and latency of changes in voltage provide insight into the magnitude and timing of
information processing in the brain [87,136]. The present systematic review focuses on ‘cognitive’ ERPs
occurring at least 150 ms post-stimulus, reflecting higher order cognitive processes such as executive
functioning, memory encoding and retrieval, and semantic processing [102]. Previous research on
earlier sensory components has relatively consistently revealed intact early components in groups with
AD compared to healthy older adult groups, suggesting that more automatic perception of stimuli may
remain intact, while more complex cognitive processing of such stimuli declines, at least in mild to
moderate AD [51,78,102]. Considering ERPs as biomarkers of AD-related neuropathology could expand
upon the spatial knowledge provided by structural and functional MRI studies and enhance
understanding of the temporal nature of communication and connectivity of neural networks
associated with AD.
Most recent neuroimaging studies have used MRI, fMRI, and positron emission tomography (PET) to
examine MCI and AD. Overall, AD studies demonstrate reduced regional brain volume and cortical
thickness, and decreased activation in the amygdala, hippocampus, inferior and medial temporal lobes,
anterior cingulate cortex, and regions of the prefrontal cortex (e.g., orbitofrontal) and parietal lobes
[79,98,119] relative to typical aging. Additionally, while typical aging may be accompanied by a
widespread decline in functional connectivity, exaggerated decline is observed in those with AD,
especially in regions associated with the default mode network, such as posterior cingulate cortex,
medial prefrontal cortex, inferior parietal lobules, lateral temporal cortices, and the hippocampi [37].
Findings in MCI are more varied, sometimes indicating increased activation and other times indicating
decreased activation in AD-relevant regions, such as the medial temporal lobe and the default mode
network. This variability is largely attributed to task differences (e.g., cognitive demand) and variation
in MCI and AD severity across studies [33,153].
Studies of early indicators of neural decline in healthy, cognitively intact APOE ε4 carriers compared to
non-carriers are scarce. The available research with fMRI suggests that cognitively intact ε4 carriers
exhibit a period of increased, compensatory activation relative to their lower risk counterparts
[14,121,130]. Yet, over time, activation in ε4- steadily increases while in ε4+ it decreases, becoming
more comparable with what is seen with MCI and AD, indicative of advancing neuropathology [121].
Whereas fMRI has exceptional spatial localization, ERPs compliment and expand upon this research by
providing a more direct and temporally precise understanding of neural processes. While fMRI signals
are a proxy for neural activity, generated seconds afterward by capillary-level blood oxygenation, ERPs
directly capture neuronal activity with millisecond-level precision [85,87]. Furthermore, individuals that
are unable or unwilling to undergo MRI scans can still participate in EEG sessions. This non-invasive and
relatively low-cost option is viable for individuals with medical devices such as pacemakers, joint
replacements and other implants, high body mass index, tattoos, extensive dental work, and anxiety
about confined spaces. These advantages make EEG and ERPs particularly appealing as a form of early
detection of AD risk.
This present study is a systematic review of MCI, AD, and intact APOE ε4-carrier groups relative to
healthy controls with ERPs reflecting higher cognitive functions (defined herein as ≥150 ms poststimulus onset). While reviews of ERPs in AD have been conducted [65,102], none to date have been

systematic reviews. Although a 2017 paper examined ERPs associated with MCI [58], the present
review adds studies published since that paper; assesses AD and APOE studies in comparison with MCI;
and focuses and expands evaluation of later, cognitive ERP components. The present review therefore
systematically highlights specific patterns in the literature relative to each individual component
examined; investigates variability and contradictory results; evaluates demographic and task-related
variables that may account for variable findings; and discusses pattern similarities and differences
across components that can help direct future research attempting to distinguish these groups.

2. Methods
2.1. Search strategies

Database searches were conducted in PsycINFO and PubMed for peer-reviewed articles in the English
language. MCI searches using the keywords [“ERP” OR “event-related potential”] combined with
[“MCI” OR “mild cognitive impairment”] returned a combined 169 results (69 PsycINFO; 100 PubMed).
To assure comprehensive coverage, all 42 studies from Gu and Zhang’s review [58] were added to the
initial return list, resulting in a complete initial list of 211 studies. Alzheimer’s disease and APOE
searches were conducted using the keywords [“ERP” OR “event-related potential”] combined with
[“Alzheimer’s” OR “APOE” OR “Apolipoprotein E”]. These search terms turned out a combined 379
initial articles (153 PsycINFO; 226 PubMed). Notably, there were far fewer initial returns for
APOE/Apolipoprotein-E searches (20) compared to Alzheimer’s or MCI (359 and 211, respectively).

2.2. Article selection

Fig. 1 displays the overall process for study exclusion. As the first step of article evaluation, duplicate
articles were deleted. The remaining returns were then evaluated based on title and abstract, and
were only included in the next step if they: 1) were original, empirical studies, 2) analyzed cognitive
event-related potentials (i.e., 150 ms post-stimulus or later), 3) employed a sample of participants with
MCI, AD, or intact participants deemed at risk for AD as carriers of the APOE ε4 allele, and 4) compared
an MCI/AD/APOE ε4 group with a healthy older adult control group. Studies that survived this title and
abstract review were subjected to full article evaluation. Studies excluded at this phase failed criteria
for the following reasons: non-empirical study (n = 16), no between-group comparison of cognitive
ERPs (n = 20), no AD/MCI group (n = 12), no healthy older adult control group (n = 12), a sample
size < five participants per group (n = 1), use of non-traditional MCI subjects (e.g., MCI in stroke
patients; n = 3), and single trial methodology not comparable with other studies (n = 1). Note that some
excluded papers failed multiple inclusion criteria, but each was recorded under one category for
simplicity. The final samples included in the review were 47 MCI, 47 AD, and 6 APOE ε4 studies.

Fig. 1. Article selection process for a. MCI studies, and b. AD and APOE ε4 studies.

3. Results

The 47 MCI, 47 AD, and six APOE studies reviewed herein are described in Table 1 (MCI) and Table
2 (AD, APOE). These studies overall identified several cognitive ERP components that may be altered in
the progression of AD-related neuropathology. The most frequently investigated components were
N200 (21 MCI, 13 AD, 4 APOE), P300 (30 MCI, 33 AD, 5 APOE), and N400 (6 MCI, 16 AD, 1 APOE).
Although rarely investigated, some studies examined the late positive component (LPC, aka P600), the
parietal old/new effect, late slow waves, the late positive potential (LPP), and some other uncommon
components (e.g., N250 r, C250, contingent negative variation (CNV)). Study of components with less
than three supporting articles are not comprehensively discussed [e.g., 21,24,27,44], but are included
in Table 1, Table 2.

Table 1. Results of MCI Studies Included in the Review.
Authors (Year) ERP Task(s)

ERP Component(s)

Electrodes

Amplitude Effects

Latency Effects

Ally et al.
(2009)

Recognition
memory

N4001, PE, LFE

ROIs (7 site avg): LAI,
RAI, LAS, RAS, LPS, RPS,
LPI, RPI

–

Bennys et al.
(2011)

Auditory oddball

N200; P300

Fz, Pz

N4001 (LAI, LAS, RAS):
MCI < HC; PE (LPS): MCI < HC
(tr); LFE: MCI > HCp (LAI,
LAS), MCI < HCw (RAS)
N200 (Pz): MCIa<MCIb,HC;
P300 (Pz): MCIa<MCIb,HC

Bennys et al.
(2007)

Auditory oddball

N200; P300

Fz, Pz

NS

Broster et al.
(2018)
Cespon et al.
(2013)
Cespon et al.
(2015a)
Cespon et al.
(2015b)

Emotive images,
WM (DMS)
Simon

LPP; LPC

Peak site, each PCA

N2pc

PO7, PO8 (DW)

LPP (Fz, Pz): MCI < HC; LPC
(Fz, Pz): MCI < HC
MCI < HC

Simon

N2pc; N2cc

Simon

N200; N2pc; P300

Chan et al.
(2013)

Visual tool-using
gesture

P300

Chiang et al.
(2015)

Semantic
retrieval

Chiang et al.
(2018)
Cid-Fernández
et al. (2014)

Semantic go/nogo
Go/no-go

Left frontotemporal effect;
fronto-parietal
effect
N200; P300

N2pc: PO7, PO8 (DW);
N2cc: C3, C4 (DW)
N200, P300: Fz, Cz, Pz,
Oz; N2pc: PO7, PO8
(DW)
FP1, FP2, F7, F3, Fz, F4,
F8, T3, C3, Cz, C4, T4,
T5, P3, Pz, P4, T6, O1,
Oz, O2
62 sites (PCA)

N200; P300

N200: Fz, FCz, Cz (avg);
P300: FCz, Cz, Pz (avg)
Cz, Pz

Reference
(text)
[1]

N200 (Fz, Pz):
MCIa>HC; P300 (Pz):
MCIa>MCIb,HC
N200 (Fz, Pz):
MCI > HC; P300 (Fz,
Pz): MCI > HC
–

[12]

NS

[20]
[21]

N200: NS; N2pc: MCId<HC;
P300: NS

N2pc: NS; N2cc:
MCId> HC
N200 (Pz): MCId>HC;
N2pc: NS; P300: NS

MCI < HC (F4, P3, Pz, T5, T6)

NS

[23]

Left fronto-temporal: NS;
Fronto-parietal (FP1, F3, Pz,
P2): MCI > HC

–

[27]

NS

N200: MCI > HC (tr)

[28]

N200 (Cz): MCI < HC; P300:
NS

NS

[29]

N2pc: MCId<HC; N2cc: NS

[11]
[16]

[22]

Cid-Fernández
et al. (2017)

Go/no-go

N200; P300; PSW

Fz, Cz, Pz

N200^: Go
MCId>HC; P300: NS;
PSW: –
NS

[30]

FC4, C4, CP4

N200^: Go MCIc<HC; No-go
MCIc, MCId<HC; P300: NS;
PSW (Cz, Pz): MCIc>MCId,HC
MCId<HC (C4, CP4)

Deiber et al.
(2011)
Fraga et al.
(2018)
Frodl et al.
(2002)
Galli et al.
(2010)
Golob et al.
(2007)
Golob et al.
(2002)
Gozke et al.
(2016)
Gu et al.
(2017)
Gu et al.
(2018)
Hoppstadter
et al. (2013)
Invitto et al.
(2018)

Face/letter DMS

N250r

N-back

P450

–

MCI < HC (P4)

–

[44]

Auditory oddball

P300

F3, F4, P3, P4

NS

NS

[46]

Identificationpriming
Auditory oddball

N4001, PE

–

[48]

P300

F7, Fz, F8, FT7, FCz, FT8, N4001(left fronto-central):
T3, Cz, T4, T5, Pz, T6
MCI < HC; PE: NS
Pz
–

MCIc>HC (Pz)

[50]

Auditory oddball

N200; P300

N200: Cz, P300: Pz

NS

[51]

Visual oddball

N200; P300

Fz, Cz, Pz

N200: NS; P300^: MCI < HC

N-back

P300

MCI < HC (CPz, CP2, P1, P2)

N-back

P300

MCI < HC (CP2, P1, Pz, P2)

NS

[57]

Recognition
memory
Olfactory
oddball

N4001, PE

N4001(anterior RH):
MCI < HC; PE: NS
MCI > HC (F7(LH)); MCI < HC
(F8(RH))

–

[64]

–

[67]

Lai et al.
(2010)

Auditory oddball

N200; P300

CP1, CPz, CP2, P1, Pz,
P2
CP1, CPz, CP2, P1, Pz,
P2
ROIs (6 site avg): RH,
LH; anterior, posterior
Fp1, Fp2, F3, Fz, F4, C3,
Cz, C4, Pz, P7, P8, O1,
O2, F7, F8
Fz, Cz, Pz

N200: NS; P300 (Pz):
MCI > HC
N200^: MCI > HC;
P300^: MCI > HC
NS

NS

Li et al. (2016)

DMS

N200; P300

N200: NS; P300^: MCI < HC

Li et al. (2010)

Auditory oddball

N200; P300

N200: F3, Fz, F4, FCz,
C3, Cz, C4; P300: O1,
O2, Pz
N200: Cz; P300: Pz

N200: NS; P300 (Pz
[78]
@ baseline, Cz, Pz @
follow-up) MCI > HC
NS
[81]

Li et al. (2017)

WM (DMS)

P300

F3, F5, F7, F4, F6, F8

N200: NS; P300 (Pz):
MCI < HC
MCI > HC (LH)

N200: NS; P300 (Pz):
MCI > HC
–

LPC

[36]

[53]
[59]

[83]
[82]

Lopez Zunini
et al. (2016)
Missonier et
al. (2007)
Mudar et al.
(2015)
Olichney et al.
(2002)
Papadaniil et
al. (2016)
Papaliagkas et
al. (2008)

Go/no-go

N200; P300

Fz, FCz, Cz, CPz, Pz

N200: NS; P300 (all):
MCI < HC
–

NS

[86]

N-back

N200

F3, Fz, F4, C3, Cz, C4

^MCIa>MCIb,HC

[90]

Semantic go/nogo
Word repetition

N200; P300

N200: Fz, FCz, Cz (avg);
P300: FCz, Cz, Pz (avg)
F7, F8, Cz, T5, T6, O1,
O2; ROIs
Pz

NS

N200: MCI > HC;
P300: NS
N400^: MCI > HC;
LPC: NS
NS

[94]

Auditory oddball

P300

Auditory oddball

N200; P300; slow
wave

Cz, Pz

N200^: MCI > HC; P300: NS;
SW: –

[106]

Auditory oddball

N200; P300; slow
wave

Cz, Pz

N200^: MCI > HC; P300: NS;
SW: –

Phillips et al.
(2004)
Pietto et al.
(2016)
Ramos-Goicoa
et al. (2016)
Sinai et al.
(2010)
Stothart et al.
(2015)

Sternberg

P300

Pz

NS

N200: NS; P300^:
MCI > HC; SW^:
MCI > HC
N200^: MCI > HC;
P300: NS; SW^:
MCI > HC
NS

Papaliagkas et
al. (2011)

Visual shortterm memory
Stroop

LPP

[116]

NS

[120]

"Switch cost"
negative slow wave
P300

MCI < HC (right FC, CP;
left/right avg CP)
N200: NS; P300 (Pz):
MCI > HC
MCI > HC^

–

Task switching

Left, Right, and FC, CP,
PO (avg)
N200: AFz, Fz, Cz; P300:
Fz, Cz, Pz
FPz, Fz, FCz,Cz, CPz, Pz

–

[131]

NS

NS

[133]

Taler et al.
(2009)
Tsai et al.
(2016)
Tsolaki et al.
(2017)
van Deursen
et al. (2009)

Semantic
priming
Task-switching

N400

MCI > HC (Pz)

–

[137]

P300

Occiptial ROI O1, Oz,
O2, PO9, P10, PO7, PO8
(avg)
Fz, FCz, Cz, CPz, Pz; 4site LH-RH avg
Fz, Cz, Pz

MCI < HC^

MCI > HC^

[138]

Two-tone
auditory oddball
CNV paradigm;
auditory oddball

P300

Pz

NS

NS

[139]

CNV; N200; P300

Fz, Cz, Pz

NS

CNV: –; N200: NS;
P300 (Pz): MCI > HC

[142]

Visual oddball

N400; LPC

N200; P300

N400: NS; LPC^: MCI < HC
NS

[100]
[105]

[107]
[114]

Wang et al.
(2013)
Waninger et
al. (2018)

Flanker

N200; P300

Vigilance; image
recognition

LPP

White et al.
(2018)
Yang et al.
(2015)

Letter-face
paradigm
Face recognition

P300
N4001, PE

N200: F3, Fz, F4 (avg);
P300: P3, Pz, P4 (avg)
Fz, F3, F4, Cz, C3, C4,
P3, P4, Pz, O1, O2, T5,
T3, F7, Fp1,Fp2, F8, T4,
T6, POz
Cz, Pz

N200: MCI < HC; P300:
MCI < HC
MCI < HC (all)

N200: MCI > HC;
P300: MCI > HC
–

[145]

MCI < HC (Cz, Pz)

MCI > HC (Pz)

[148]

Avg; F (F5, Fz, F6), C
(C5, Cz, C6), P (P5, Pz,
P6), O (CB1, Oz, CB2)

N4001: NS; PE (central,
parietal): MCI < HC

N4001:NS; PE: –

[154]

[146]

Notes: MCI = Mild Cognitive Impairment; HC = older adult controls; A = amplitude; L = latency; LH = left hemisphere; RH = right hemisphere;
DW = difference wave; ROI = region of interest; PCA = principal components analysis; WM = working memory; – = data not
available/reported; avg = average(s); tr = non-sigificant trend; p = pictures; w = words; ^site(s) not specified; apMCI = progressing
MCI; bnpMCi = non-progressing (stable) MCI; csdMC = single-domain (amnestic) MCI; dmdaMCI = multi-domain amnestic
MCI; emdnaMCI = multi-domain non-amnestic MCI; faMCI = amnestic MCI; DMS = delayed match-to-sample; NS = not significant; – = not
investigated/reported; EFE1=early frontal effect (frontal N400); PE = parietal effect; LFE = late frontal effect (>1000 ms); LPP = late positive
potential; LPC = late positive component; (P)SW=(positive) slow wave; CNV = contingent negative variation; LAI/RAI = left/right anterior
inferior ROI; LAS/RAS = left/right anterior superior ROI; LPS/RPS = left/right posterior superior ROI; LPI/RPI = left/right posterior inferior ROI;
*Cohen's d, absolute value–estimated where necessary.
Table 2. Results of AD, Apolipoprotein-E ε4 Studies Included in the Review.
Authors (Year)

ERP Task(s)

Asaumi et al.
(2014)
Ashford et al.
(2011)
Auchterlonie,
Phillips, &
Chertkow (2002)
Boller et al. (2002)
Castañeda et al.
(1997)

Electrodes

Amplitude Effects

Latency Effects

Visual oddball

ERP
Component
P300

Fz, Cz, Pz, Oz

AD < HC (all)

AD > HC (all)

Reference
(text)
[3]

Auditory oddball

P300

Pz

AD < HC (Pz)

NS

[4]

Word-picture
semantic priming

N400

P3, Pz, P4

AD < HC^

–

[5]

Auditory
discrimination
Pictoral semantic
categorization

P300

–

AD < HC

AD < HC

[13]

N400, LPC

Fz, Cz, Pz, PC3, CP3, T3, TP7,
FC4, CP4, T4, TP8

N400 (all): AD < HC;
LPC: NS

N400 (all):
AD > HC; LPC: NS

[19]

Chapman, et al.
(2016)
Cheng & Pai
(2010)

Number-letter
working memory
Familiar, novel
face & scene
discrimination

2−3 site avg: frontal, central,
parietal, occipital
FP1, FP2, Fz, F3, F4, F7, F8, FCz,
FC3, FC4, FT7, FT8, Cz, C3, C4,
T7, T8, CPz, CP3, CP4, TP7, TP8,
Pz, P3, P4, P7, P8, Oz, O1, O2
Fz
Fz, Cz, Pz

NS

–

[24]

AD > HC (F3)

NS

[26]

NS
NS

[31]
[39]

3-site avg: F3, Fz, F4 (frontal);
C3, Cz, C4 (central); P3, Pz, P4
(parietal)
Fz,Cz,Pz; 3-site avg: F3, Fz, F4
(frontal); C3, Cz, C4 (central); P3,
Pz, P4 (parietal)

P300^: AD < HC (tr);
N300: NS; N400: NS

NS
N200^:
ε4/ε4 > ε3/ε4;
P300: NS
P300: –; N300: NS;
N400^: AD > HC

P300^: AD < HC;
N400^: AD > HC

AD > HC (Pz)

[43]

N400, LPC

Fz, Cz, Pz, O1, O2

AD < HC (Fz)

–

[45]

P300
P300

Cz
Fz, Cz, Pz

NS
–

NS
[47]
AD > HC (trend, Fz) [52]
N200 (all):
ε4+>ε4- P300: NS
–

[54]

N200: NS; P300
(Fz, Cz):
Mod > Mild>HC
–

[60]

N200^: AD < HC;
P300^: AD > HC

[63]

C250
N250r

Cintra et al. (2017) Auditory oddball
Espeseth et al.
Auditory oddball
(2009)

N200, P300
N200, P300

Ford et al. (2001)

Picture-name
congruity

P300, N300,
N400

Ford et al. (1996)

Auditory oddball;
Semantic,
phonemic
monitoring
Word-repetition
priming
Passive auditory
Auditory
discrimination
Auditory oddball

P300, N400

N200, P300

Fz, Cz, Pz

NS

Semantic priming

N400

AD < HC^

Auditory oddball

N200, P300

Topographic component
analysis; all electrodes
Fz, Cz

Semantic priming
terminal word
decision
Auditory oddball

N400, LPC

F3, Fz, F4, C3, Cz, C4, P3, Pz, P4,
T5, T6, O1, O2

N400^: AD < HC LPC:
NS

N200, P300

Global field power: Fp1, Fp2, F3,
Fz, F4, F7, F8, C3, Cz, C4, P3, Pz,
P4, T5, T6, O1, Oz, O2

N200: NS; P300^:
AD < HC

Friedman et al.
(1992)
Gaeta et al. (1999)
Gordon et al.
(1989)
Green & Levey
(1999)
Grieder et al.
(2013)
Gungor et al.
(2005)
Hamberger et al.
(1995)
Hirata et al.
(2000)

N200: NS; P300 (Fz,
Cz): Mod < Mild=HC

[42]

[55]

[62]

Iragui, Kutas, &
Salmon (1996)
Jacob & Duffy
(2014)
Kazmerski &
Friedman (1997)
Kazmerski,
Friedman, &
Hewitt (1995)
Kazmerski,
Friedman, & Ritter
(1997)
Kowalewski &
Murphy (2012)
Kraiuhin et al.
(1990)
Kraiuhin et al.
(1989)
Lockwood,
Vaughn, & Duffy
(2018)
Marsh et al.
(1990)
Mathalon et al.
(2003)
Morgan & Murphy
(2002)

Word pair
congruity
Word and motion
flow decision
Verbal category
recognition
Semantic
repetitions

N400

F7, F8, Cz, T5, T6, O1, O2; +ROIs

AD < HC^

AD > HC^

[68]

N200, P300

O1, Oz, O2, Pz

NS

NS

[69]

P300, N400

Fz, Cz, Pz
Fz, Cz, Pz

P300 (Cz, Pz):
AD > HC; N400: NS
AD < HC (Pz)

[71]

P300

P300 (Cz, Pz):
AD < HC; N400: NS
NS

Auditory oddball

N200, P300

Fz, Cz, Pz

NS

–

[73]

Odor-image
congruency

N400

ε4+>ε4- (RH dorsal,
ventral); ε4+<ε4- (Pz)

–

[74]

P300

12 ROIs/condition (6−7 site avg):
left/right, anterior/posterior,
dorsal/ventral, and individual
midline
Fz, Cz, Pz

–

NS

[75]

P300

Fz, Cz, Pz

–

AD > HC (Fz)

[76]

N200, N2pc,
P300, CNV

Avg: CP3, P3, T5 (LH); CP4, P4,
T6 (RH)

N200,N2pc,P300^:
AD < HC; CNV: NS

NS

[84]

P300

Pz

–

AD > HC (Pz)

[88]

P300

Fz, Cz, Pz

P300^: AD < HC

–

[89]

N200, P300

Fz, Cz, Pz

NS

N200^: AD > HC;
P300^: AD > HC

[92]

N200, P300

Fz, Cz, Pz

NS

[93]

P300

Fz, Cz, Pz

–

N200^: ε4+>ε4-;
P300^: ε4+>ε4ε4+>ε4-^

N200, P300

Fz, Cz, Pz

–

AD > HC^

[96]

Two-tone auditory
discrimination
Two-tone auditory
discrimination
Attentionally cued
orientation
discrimination
Auditory target
tone
Picture-name
verification
Single stimulus
(auditory,
olfactory)
Morgan & Murphy Visual, olfactory
(2012)
identification
Murphy et al.
Odor recognition
(2009)
O'Mahony et al.
Auditory target
(1996)
tone

[72]

[95]

Auditory target
tone
Semantic
repetition
congruity
Picture congruity
matching
Auditory oddball

P300

Fz, Pz

–

AD > HC (Fz)

[97]

N400, LPC

Fz, F7, F8, Cz, Pz, T5, T6, O1, O2;
ROI's

AD < HC^

N400^: AD > HC
(tr); LPC: –

[99]

N400

AD < HC (all)

NS

[103]

P300

Fz, Cz, Pz, Oz, FC3, CP3, T3, TP7,
FC4, CP4, T4, TP8
Pz

NS

AD > HC (Pz)

[105]

Auditory oddball

N200, P300

Fz, Cz, Pz

NS

AD > HC^

[110]

Auditory oddball

P300

Fz

–

AD > HC (Fz)

[111]

Sternberg working
memory
Target-tone
auditory
discrimination
Semantic priming
congruity

P300

Pz

AD < HC (Pz)

NS

[114]

N200, P300

Fz, Cz, Pz

N200: NS; P300^:
AD < HC

AD > HC^

[118]

N400, LPC

AD < HC^

–

[123]

Rugg et al. (1994)

Word repetition,
infrequent targets

P300; N400

NS

NS

[126]

Schwartz et al.
(1996)
Sumi et al. (2000)
Taler,
Klepousniotou, &
Phillips (2009)
Tsolaki et al.
(2017)
van Deursen et al.
(2009)

Categorical
semantic priming
Auditory oddball
Semantic priming

N400, LPC

N400^: AD < HC; LPC:
NS
–
Raw (CPz, Pz):
AD > HC; Priming: NS

N400^: AD > HC;
LPC: –
AD > HC (Pz)
–

[129]

N200, P300
N400

FP1, FP2, F7, F8, F3, F4, Fz, T3,
T4, C3, C4, Cz, T5, T6, P3, P4, Pz,
O1, O2, Oz
Fz, Cz, Pz, 50 % distance from:
F3:F7, F4:F8, C3:T3, C4:T4,
P3:T5, P4:T6
Fz, F7, F8, Cz, Pz, T5, T6, O1, O2;
ROIs
Pz
Fz, FCz, Cz, CPz, Pz

Two-tone auditory
oddball
Auditory target
tone oddball; CNV
paradigm

P300

Pz

NS

AD > HC (Pz)

[139]

N200, P300,
CNV

Fz, Cz, Pz

N200,CNV: NS P300
(Cz, Pz): AD < HC

N200: NS; P300
(Fz, Cz): AD > HC

[142]

O'Mahony et al.
(1993)
Olichney et al.
(2006)
Ostrosky-Solis et
al. (1998)
Papadaniil et al.
(2016)
Patterson,
Michalewski, &
Starr (1988)
Pedroso et al.
(2018)
Phillips et al.
(2004)
Polich, Ladish, &
Bloom (1990)
Revonsuo et al.
(1998)

[135]
[137]

Wang et al. (2013)
Wetter & Murphy
(2001)
Wolk et al. (2005)
Yamaguchi et al.
(2000)

Eriksen flanker
Auditory, olfactory
identification
Recognition,
conceptual fluency
Auditory oddball

N200, P300
N200, P300

N200: F3, Fz, F4; P300: P3, Pz, P4
Fz, Cz, Pz

AD < HC^
NS

AD > HC (tr)^
ε4+>ε4-^

[145]
[147]

N400, LFE

N400: FPz, Fz, Cz, Pz, Oz; LFE:
FPz, Fz
Fz, Cz, Pz

N400^: AD < HC;
LFE^: AD < HC (trend)
AD < HC (all)

–

[150]

AD > HC (all)

[152]

P300

Notes: AD = Alzheimer's disease; FH = family history of AD; HC = older adult controls; A = amplitude; L = latency; LH = left hemisphere;
RH = right hemisphere; Mod = moderate; NS = not significant; – = data not available/reported; ^site(s) not specified; avg = average(s);
tr = non-significant trend PE = parietal effect; LFE = late frontal effect (>1000 ms); LPC = late positive potential; CNV = contingent negative
variation.

3.1. Study characteristics
3.1.1. Sample size
Study demographics and other characteristics are shown in Table 3 (MCI) and Table 4 (AD, APOE). This
review covers a total of 3922 participants (2,359 MCI v. HC; 1,445 AD v. HC; 118 APOE ε4+/-). Within
each study type (MCI, AD, or ε4), sample size was not significantly different between the comparison
groups (MCI v. HC: t(47) = 1.5, p = .15; AD v. HC: t(44) = -0.7, p = .52; ε4+ v. ε4-: t(4) = 1.0, p = .37).
However, across study type, sample size was significantly different (F(2,95) = 15.4, p<.001, ηp2=.25).
MCI studies had significantly larger samples (ps <.001; MMCI = 25.9, SD = 14.5, MED = 22.5, range = 5–
91; MHC = 23.2, SD = 11.0, MED = 20, range = 6–63) than AD studies (MAD = 15.2, SD = 7.1, MED = 14,
range = 6–36; MHC = 15.6, SD = 6.7, MED = 15, range = 8–39) and ε4 studies (Mε4+ = 12, SD = 5.1,
MED = 10, range = 9–21; Mε4- = 11.6, SD = 4.8, MED = 10, range 8–20), which did not significantly differ.
Some MCI studies subdivided their samples by MCI type, resulting in group sizes generally more
comparable to those in AD studies.

Table 3. Demographic Data (mean (SD) or range, as reported) MCI Studies Included in the Review.
Authors (Year)
Ally et al. (2009)
Bennys et al. (2011)
Bennys et al. (2007)
Broster et al. (2018)
Cespon et al. (2013)
Cespon et al.
(2015a)
Cespon et al.
(2015b)
Chan et al. (2013)
Chiang et al. (2015)
Chiang et al. (2018)
Cid-Fernández et al.
(2014)
Cid-Cernández et al.
(2017)
Deiber et al. (2011)
Fraga et al. (2018)
Frodl et al. (2002)
Galli et al. (2010)
Golob et al. (2007)
Golob et al. (2002)
Gozke et al. (2016)
Gu et al. (2017)
Gu et al. (2018)
Hoppstadter et al.
(2013)
Invitto et al. (2018)
Lai et al. (2010)
Li et al. (2016)

Total N^ MCI N HC
N
36
18
18
102
71
31
60
20
10
32
16
16
55
30
25
43
25
18

MCI Age

HC Age

MCI MMSE

HC MMSE

71.8 (9.2)
70.7 (9.0)a 72.0 (7.8)b
64.4 (7.6)
77.2 (1.5)
67.0 (9.1)c 71.0 (9.2)d
69.1 (2.0)c 71.2 (2.1)d

74.6 (4.1)
71.2 (9.2)
61.6 (6.4)
76.7 (1.4)
65.2 (8.2)
68.3 (1.7)

28.1 (1.3)
25.4(3.2)a 26.4 (2.7)b
27.0 (1.6)
26.2 (0.7)
27.2 (1.9)c 23.5 (1.7)d
26.9 (0.5)c 23.7 (0.5)d

29.4 (0.8)
29.5 (0.6)
29.6 (0.5)
28.8 (0.3)
28.4 (1.3)
28.5 (0.4)

Reference
(text)
[1]
[12]
[11]
[16]
[20]
[21]

53

38

15

66.0 (7.5)

[22]

17
16
25
30

17
17
25
63

24.4 (2.4)e 27.2
(1.9)c 23.7 (1.6)d
23.2 (5.1)
28.3 (1.3)
–
25.9 (2.4)

28.3 (1.2)

50
33
50
93

66.5 (9.7)e 67.1
(9.3)c 69.6 (9.0)d
70.7 (7.9)
69.7 (7.9)
68.5 (8.0)
69.5 (8.2)

28.3 (1.6)
28.4 (0.9)
–
28.2 (1.5)

[23]
[27]
[28]
[29]

54

34

20

68.7 (10.1)c 72.1 (6.9)d 67.0 (9.8)

26.9 (2.0)c 23.4 (1.7)d

28.0 (1.5)

[39]

79
63
82
32
134
23
40
82

43
21
26
17
41
15
20
39

36
27
26
15
44
12
20
43

65.8 (5.4)c 64.0 (5.3)d
79.9 (1.1)
66.2 (11.3)
73.1 (4.9)
74.6 (5.9)c 76.0 (5.2)d
76.5 (2.7)
66.0 (3.6)
71.2 (5.4)g 71.3 (6.3)h

28.2 (1.5)c 27.7 (1.9)d
–
27.5 (1.6)
25.5 (3.4)
27.4 (1.6)c 27.4 (2.4)d
27.7 (1.9)
–
26.9 (2.6)g 27.2 (1.9)h

39
14

46
10

71.3 (6.0)
68.0 (4.0)

27.1 (2.1)
27.9 (1.3)

29.0 (0.8)
–
29.7 (0.5)
28.9 (0.8)
29.0 (1.1)
29.2 (0.8)
–
28.1 (1.6)g 28.7
(1.1)h
28.4 (1.3)
28.9 (1.1)

[36]
[44]
[46]
[48]
[50]
[51]
[53]
[59]

85
24

64.7 (6.6)
77.6 (1.0)
64.9 (10.9)
70.4 (5.7)
75.1 (5.7)
72.8 (7.8)
66.3 (4.4)
70.2 (5.3)g 70.2
(5.7)h
70.2 (5.6)
67.8 (4.7)

24
32
46

12
18
24

12
14
22

70.3 (7.7)
68.0 (8.7)
69.3 (7.6)

66.4 (5.7)
64.8 (7.8)
69.2 (8.9)

–
23.1 (0.8)
26.4 (2.1)

–
28.3 (1.5)
29.0 (1.0)

[67]
[78]
[81]

67.9 (6.7)
64.9 (6.6)
65.4 (7.1)
65.9 (8.0)

[57]
[64]

Li et al. (2010a)
Li et al. (2017)
Lopez Zunini et al.
(2016)
Missonier et al.
(2007)
Mudar et al. (2015)
Olichney et al.
(2002)
Papadaniil et al.
(2016)
Papaliagkas et al.
(2008)
Papaliagkas et al.
(2011)
Phillips et al. (2004)
Pietto et al. (2016)

68
48
32

34
17
15

34
18
17

72.5 (5.4)
75.3 (9.2)
75.6 (6.0)

71.6 (5.7)
75.1 (5.0)
72.8 (5.9)

24.4 (3.8)
27.8 (1.8)
–

28.1 (1.5)
29.3 (0.8)
–

[83]
[82]
[86]

55

29

16

82.1 (5.3)a 82.0 (9.0)b

71.6 (9.0)

25.5 (1.8)a 26.7 (1.9)b

28.6 (1.2)

[90]

50
28

25
14

25
14

68.5 (8.0)
74.6

65.4 (7.1)
74.0

28.4 (1.3)
27.0 (1.7)

28.6 (0.5)
–

[94]
[100]

63

21

21

72.0 (4.7)

67.0 (2.7)

27.0 (1.4)

28.8 (0.9)

[105]

121

91

30

66.6 (5.4)

68.9 (9.9)

27.7

29.7

[106]

52

22

30

67.4 (7.8)

–

27.9 (1.9)

–

[107]

45
47

15
23

16
24

75.8 (6.4)
73.1 (9.0) 44.4 (3.2)

27.6 (2.1)
26.5 (2.5) 25.2 (4.5)

84

39

45

70.7 (9.1)

28.8 (1.2)
29.5 (0.5) 29.1
(1.1)
28.5 (1.3)

[114]
[116]

Ramos-Goicoa et al.
(2016)
Sinai et al. (2010)

75.2 (5.5)
67.2 (10.1) 44.3
(5.6)
65.4 (9.2)

46

27

19

75.7 (1.5)

[131]

71

25

26

76.0 (7.0)

28.4 (0.4)j 26.2
(0.8)k 25.2 (0.8)l
25.9 (1.9)

28.6 (0.4)

Stothart et al.
(2015)
Taler et al. (2009)
Tsai et al. (2016)
Tsolaki et al. (2017)
van Deursen et al.
(2009)
Wang et al. (2013)
Waninger et al.
(2018)
White et al. (2018)
Yang et al. (2015)

75.5 (1.7)j 77.0
(2.9)k 76.5 (2.6)l
77.3 (7.4)

28.5 (1.2)

[133]

49
60
63
55

20
30
21
20

19
30
21
20

75.8 (7.6)
68.2 (5.3)
72.0 (4.7)
70.6 (7.2)

74.7 (7.6)
66.9 (4.4)
67.0 (2.7)
69.5 (6.1)

27.4 (2.3)
27.6 (2.0)
27.0 (1.4)
26.3 (1.6)

–
28.6 (1.2)
28.8 (0.9)
29.3 (0.8)

[137]
[138]
[139]
[142]

38
∼35

15
18

16
17

72.9 (1.9)
69.0 (0.4)

69.3 (1.8)
67.3 (1.6)

27.0 (0.5)
27.9 (0.5)

29.3 (0.5)
29.2 (0.2)

[145]
[146]

5
24

6
24

–
71.5 (4.5)

–
71.8 (3.7)

–
26.6 (1.9)

–
28.8 (1.4)

[148]
[154]

11
48

25.5 (2.5)

[120]

Notes: MCI = Mild Cognitive Impairment; HC = older adults (controls); – = data not available/reported; ^sample size included in analyses;
Mod = moderate; aprogressing MCI; bnon-progressing (stable) MCI; csingle-domain (amnestic) MCI; dmulti-domain amnestic MCI; emultidomain non-amnestic MCI; famnestic MCI; gε4+; hε4-; ifamilial AD; jMCI-able; kMCI-cue; lMCI-unable; ∼all participants consulted memory
disorder clinic; †included 3 participants with cardiovascular (multi-infarct) dementia; ‡AD group included individuals with
neuropsychological memory deficits with no known cause or probable AD.
Table 4. Demographic Data (mean (SD) or range, as reported) AD, APOE Studies Included in the Review.
Authors (Year)

Total N^ AD N

HC N

AD Age

HC Age

Asaumi et al.
(2014)
Ashford et al.
(2011)
Auchterlonie et al.
(2002)
Boller et al. (2002)

∼48

36

12

74.1 (7.2)

71.0 (5.9)

48

23

11

63−93

61−80

24

9

15

79.3 (4.2)

70.7 (5.7)

22

10

12

75 (8.1)

75 (6.2)

Castañeda et al.
(1997)
Chapman, et al.
(2016)
Cheng & Pai (2010)

20

10

10

59−89

54−82

108

36

36

74.9 (7.4)

74.2 (7.1)

37

20

17

71.1 (8.2)

69.5 (9.6)

Cintra et al. (2017)
Espeseth et al.
(2009)
Ford et al. (2001)

65
41

17
–

14
20a 13b 8c

76.3 (7.9)
–

74.5 (9.3)
63.4(8.7)a 62.9(8.7)b 60.5(9.7)c

39

13

13

74.5 (8.2)

73.8 (5.7)

Ford et al. (1996)

36

12

12

57−82

58−76

Friedman et al.
(1992)
Gaeta et al. (1999)
Gordon et al.
(1989)

30

10

10

70.6 (9.2)

16
39

8
8

8
31

72.5 (7.5)
81.0 (7.8)

AD
MMSE
20.7
(3.1)
16.6
(7.3)
–

HC MMSE
28.8 (0.9)

Reference
(text)
[3]

28.8 (1.7)

[4]

–

[5]

19.6
(2.9)
–

28.8 (1.2)

[13]

–

[19]

24.6
(2.7)
21.8
(3.4)
–
–

29.1 (0.9)

[24]

28.4 (1.7)

[26]

–
–

[31]
[39]

29.8 (0.4)

[42]

28.2 (1.3)

[43]

69.8 (6.3)

20.5
(2.7)
20.3
(3.6)
–

–

[45]

72.8 (6.5)
71.0 (4.1)

–
–

–
–

[47]
[52]

Green & Levey
(1999)
Grieder et al.
(2013)
Gungor et al.
(2005)

40

–

23f 9dg 8eg –

55.4 (4.4)f 55.5(5.0)g

–

–

[54]

38

14

19

66.5 (9.6)

69.5 (3.1)

28.7 (0.9)

[55]

32

12h 10i 10

71.2 (5.2)

29.4 (0.5)

[60]

Hamberger et al.
(1995)
Hirata et al. (2000)

26

6

10

72.5
(6.8)h 71.8
(5.8)i
67.1 (3.4)

24.8
(3.9)
19.4
(3.2)

67.0 (4.7)

–

–

[62]

38

26

12

72.2 (7.5)

69.0 (3.3)

29 (1.3)

[63]

Iragui et al. (1996)

36

12

12

70.0 (7.8)

72.0 (5.4)

29.5 (0.9)

[68]

Jacob & Duffy
(2014)
Kazmerski &
Friedman (1997)
Kazmerski et al.
(1995)
Kazmerski et al.
(1997)
Kowalewski &
Murphy (2012)
Kraiuhin et al.
(1990)
Kraiuhin et al.
(1989)
Lockwood et al.
(2018)
Marsh et al. (1990)

49

14

17

73.6 (2.1)

77.0 (1.8)

18.6
(4.3)
22.3
(3.4)
27 (0.7)

28.6 (0.3)

[69]

32

8

8

68.8 (2.7)

69.3 (7.3)

–

–

[71]

32

8

8

67.9 (8.3)

68.4 (5.4)

–

–

[72]

48

16

16

68.7 (6.6)

69.1 (6.5)

–

–

[73]

20

–

10d 10e

–

69.6(5.0)d 69.0(3.5)e

–

–

[74]

40

14

15

79.4 (61−90)

74.0 (61−92)

–

–

[75]

30

15

15

79.4 (61−90)

–

–

–

[76]

55

13

19

73.3 (1.6)

71.2 (1.4)

29.0 (0.2)

[84]

35

18

17

65.2 (5.8)

64.4 (6.7)

29.6 (0.7)

[88]

Mathalon et al.
(2003)
Morgan & Murphy
(2002)

32

12

10

76.2 (5.7)

75.3 (5.1)

29.6 (0.5)

[89]

24

12

12

72.8(7.3)

73.9(6.4)

24.8
(0.9)
24.7
(1.3)
20.7
(2.7)
–

–

[92]

[93]

Morgan & Murphy
(2012)
Murphy et al.
(2009)
O'Mahony et al.
(1996)
O'Mahony et al.
(1993)
Olichney et al.
(2006)
Ostrosky-Solis et al.
(1998)
Papadaniil et al.
(2016)
Patterson et al.
(1988)
Pedroso et al.
(2018)
Phillips et al. (2004)

20

–

10d 10e

–

70.2(2.9)d 71.2(3.6)e

–

–

20

–

10d 10e

–

75.1(8.3)d 71.0(6.1)e

–

27.0(2.7)d 26.1(2.8)e [95]

30

18

12

74.5 (4.3)

72.7 (4.7)

–

–

[96]

57

16

15

78.0 (5.7)

77.5 (3.8)

28.9 (1.1)

[97]

22

11

11

79.4 (7.2)

77.1 (2.9)

29.6 (0.5)

[99]

30

10

10

75.4 (5.2)

67.8 (4.7)

27.2 (3.8)

[103]

63

21

21

70.0 (6.8)

67.0 (2.7)

28.9 (0.9)

[105]

50

15†

15

60−86

57−81

28.1 (1.4)

[110]

54

24

30

76.9 (5.3)

74.1 (5.6)

24.6 (4.0)

[111]

45

14

15

70.6 (7.0)

75.2 (5.5)

28.8 (1.2)

[114]

Polich et al. (1990)
Revonsuo et al.
(1998)
Rugg et al. (1994)

32
26

16‡
9

16
17

–
67.1 (8.3)

–
64.7 (4.0)

23.4
(1.9)
22.9
(3.9)
16.5
(3.9)
22.6
(3.4)
18.3
(4.8)
19.8
(4.5)
22.9
(3.7)
–
18 (6.7)

–
27.7 (1.8)

[118]
[123]

38

11

11

68.5 (7.1)

64.9 (5.1)

28 (1.5)

[126]

Schwartz et al.
(1996)
Sumi et al. (2000)
Taler et al. (2009)
Tsolaki et al. (2017)

36

12

12

67−81

63−86

20.6
(3.3)
–

–

[129]

108
49
63

34
10
21

39
19
21

70.0 (6.6)
82.4 (5.4)
70.0 (6.8)

68.5 (4.9)
74.68 (7.6)
67.0 (2.7)

–
–
28.81 (0.9)

[135]
[137]
[139]

van Deursen et al.
(2009)
Wang et al. (2013)

55

15

20

75.2 (6.9)

69.5 (6.1)

29.3 (0.8)

[142]

38

7

16

68.6 (2.9)

69.3 (1.8)

–
–
22.6
(3.4)
20.8
(2.7)
21.5
(0.8)

29.3 (0.5)

[145]

Wetter & Murphy
(2001)
Wolk et al. (2005)

20

–

10d 10e

–

75.7(7.7)d 75.3(6.4)e

–

28.2(1.1)d 28.5(1.1)e [147]

24

12

12

55−80

65−86

29.3

[150]

Yamaguchi et al.
(2000)

50

16

18

68.5 (8.0)

69.6 (9.3)

25.1
(3.2)
–

–

[152]

Notes: AD = Alzheimer's disease; HC = older adults (controls); aε3/ε3; bε3/ε4; cε4/ε4; dε4+; eε4-; fAD family history-; gAD family
history+; hmild AD; imoderate AD; – = data not available/reported; ^sample size included in analyses; ∼all participants consulted memory
disorder clinic; †included 3 subjects w/multi-infarct dementia;‡AD group included subjects w/memory deficits with no known cause or
probable AD.

3.1.2. Group ages
Most but not all studies reported group age statistics. Between study type (MCI, AD, or ε4), average
age did not significantly differ (F(2,71) = 1.2, p>.10, ηp2=.03). However, the average age of the
comparison groups was significantly different across investigations (F(1,71) = 9.5, p<.003, ηp2=.12).
Specifically, healthy controls tended to be younger than the diagnostic group in both studies of MCI
(t(32) = 5.4, p < .001; MMCI = 71.3, SD = 3.8, range = 64.4–79.9; MHC = 69.5, SD = 4.1 range = 61.6−77.6)
and studies of AD (t(36) = 3.3, p < .002; MAD = 72.9, SD = 4.5, range = 65.2–82.4; MHC = 71.0, SD = 2.1,
range = 64.4–77.5). In the small number of ε4 studies, age was similar across comparison groups
(t(3) = 0.95, p = .42; Mε4+ = 72.7, SD = 3.2; range = 69.6−75.7; Mε4- = 71.6, SD = 2.6; range = 69.0–75.3).
The actual differences between comparison groups may even be greater than we report, since some
studies could not be tabulated due to only reporting age ranges; in some cases there were greater
extremes than we report (e.g., MCI studies youngest reported age was 40 years).
3.1.3. MMSE scores
The Mini-Mental State Examination (MMSE) was used in most studies to assess general cognitive
functioning [41], although group scores were reported in only 38/47 (i.e., 81 %) MCI studies, 28/47 (60
%) AD studies, and 2/6 (33 %) APOE studies. The two APOE studies that reported MMSE scores had an
average score of 27.6 (SD = 0.85) in ε4+ groups and 27.32 (SD = 1.68) in ε4-, consistent with intact
performance. As would be expected, average MMSE score was lower in diagnostic groups than in
controls (F(1,51) = 57.5, p<.001, ηp2=.53), with MCI lower than within-study controls (MMCI = 26.7, SD =
1.4, range = 23.1–28.4; MHC = 28.9, SD = 0.5; range = 28.0–29.7; t(24) = -8.6, p < .001) and AD lower
than within-study controls (MAD = 21.6, SD = 2.7, range = 16.5–27.0; MHC = 28.7, SD = 1.0; range = 24.6–
29.8; t(27) = −15.3, p < .001). Furthermore, the severity difference between AD studies and MCI studies
for the diagnostic groups (p < .001) but not control groups (p = .50) was verified by a significant
interaction (F(1,51) = 83.3, p<.001, ηp2=.62). Yet, we note overlap of MCI, AD, and HC ranges of MMSE
scores that may have contributed to differences in study outcomes (see Table 3, Table 4). For example,
Pedroso et al.’s [111] HC group had a mean MMSE score of 24.60 (SD = 4.0), which was comparable
with many of the AD groups in other studies, while Jacob and Duffy’s [69] AD group had an average
score of 27 (SD = 0.7), exceeding the mean of many HC groups in other studies.
3.1.4. Task paradigms
Oddball paradigms were the most frequently used task across all groups, accounting for 41 % of MCI
(16/47), 49 % of AD (23/47), and 33 % of APOE (2/6) studies; most of these were auditory oddball tasks
(75 % of MCI, 96 % of AD, 100 % of APOE). Oddball tasks are characterized by frequently presenting a
standard stimulus (e.g., 500 Hz tone), and occasionally presenting a novel stimulus (e.g., 1000 Hz tone).
Most of the oddball paradigms reviewed here required a response to novel stimuli (e.g., button press),
although some were passive tasks with no response. In both cases, oddball paradigms have low
cognitive demand, assessing attention and novelty detection [35]. Novel stimulus presentation is
commonly associated with N200 and P300 peaks. Indeed, 61 % of the studies analyzing N200 (i.e., MCI:
9/19, AD: 11/13, APOE: 2/4) and 57 % of those analyzing P300 (i.e., MCI: 15/30, AD: 22/33, APOE: 2/5)
used oddball tasks. Other low-demand tasks employed in the studies of this review included singlestimulus identification tasks in auditory, visual, and olfactory modalities (one AD study, 3 of 6 APOE
studies), which also analyzed N200 and/or P300 components, and one MCI study that used a visual
tool-using gesture task and focused on the P300 component.

Working memory tasks were used in 12 % of the studies reviewed, most of them in MCI studies (i.e.,
MCI: 10/47, AD: 2/47, APOE: 0/6). Working memory includes storing, manipulating, and updating
information in the short-term memory store; this is also one of the facets of executive functioning [6].
Studies reviewed here used tasks such as n-back, delayed match-to-sample (DMS), and Sternberg
paradigms. These working memory tasks highlight the relevance of N200 and P300 beyond simpler
oddball paradigms, with 7/12 working memory studies analyzing N200 and/or P300. The remaining
components examined relative to working memory included less frequently studied ERPs such as C250,
N250 r, P450, the late positive component (LPC), and the late positive potential (LPP).
Executive functions are a collection of higher-order cognitive processes responsible for organizing and
adapting goal-oriented behavior, including processes such as inhibitory control, task-switching, and
updating of working memory [91]. Only 15 % of the 100 studies reviewed examined these tasks.
Twelve MCI studies used them (i.e., 26 %, 12/47), including go/no-go, Stroop, flanker, and taskswitching paradigms. As with oddball and working memory-specific studies, these studies primarily
analyzed N200 and P300 components. Some included less frequently studied N200 subcomponents
such as N2pc and N2cc, and two studies also analyzed later slow wave potentials. Notably, almost all of
these studies were done in MCI; only three AD studies (6 %; selective attention and flanker tasks), and
no APOE studies, used executive functioning tasks.
Semantic processing involves encoding, storage, and retrieval of meaning associated with concepts and
categories, and episodic memory examines delayed retention and retrieval of recently learned memory
sets [140]. These higher-order tasks have seen less frequent ERP study than simpler tasks; overall, 28 %
of the studies reviewed included them. A much smaller proportion of MCI studies (i.e., 4/47; 9 %) used
semantic tasks, compared with AD studies (i.e., 17/47; 37 %). Most of these (88 %) examined the N400
component, which is associated with language, semantic processing, and recognition memory [77].
Some of the studies also included LPC, N300, and P300 components. Only one of the six healthy APOE
group studies (17 %) also used a semantic task, examining N400. This was the most complex of the
tasks, and the latest ERP component employed with these healthy subjects. Finally, six studies
examined episodic memory (MCI: 4/47, AD: 2/47), primarily focusing on N400, and other late
components (e.g., LPP, late frontal effect (LFE), parietal effect (PE)).
3.1.5. Electrode sites
The vast majority of studies, particularly those analyzing N200 and P300 components, analyzed only
midline electrodes (N200: 80 % of studies providing electrode information, MCI: 15/18, AD: 9/13, and
APOE: 4/4; P300: 77 %; MCI: 21/29, AD: 25/32, and APOE: 5/5). Lateral sites, however, may be uniquely
sensitive to age- and AD pathology-related neural changes [18,108,122]. Indeed, one study with
healthy APOE groups [74] found compensatory activation only in the right, non-task dominant
hemisphere in APOE ε4 carriers. Lateral electrodes may also best detect group differences for
particularly lateralized tasks, since midline electrodes might underestimate or exclude lateral activity,
depending on source distance from midline. For example, in a tool-using gesture paradigm [23], AD
differed from HC on P300 amplitude at six lateral electrodes (i.e., F3, F4, C3, P3, T5, T6), but only one
midline electrode (i.e., Pz).
Overall, group differences were generally found at sites consistent with typical component maxima,
where reported. For example, with N200, including both fronto-central and parietal electrodes,

revealed differences between MCI and HC groups; these reflect different underlying processes in N200
and may be differentially impacted by pathological aging processes [40,128]. P300 differences were
primarily found at parietal sites (the usual maxima) and sometimes at centro-parietal sites. Yet, adding
frontal electrodes was revealing in the studies that did so, in part due to capture of anterior agerelated shifts [34]. Specifically, frontal electrodes frequently added group discrimination for N200,
P300, N400, and LPC components, in addition to findings at component-specific maxima sites. This was
particularly notable for N400, despite its typically centro-parietal maxima. Similar frontal shift-related
effects were apparent in some P300 studies, but P300a and P300b were rarely distinguished, which
would be important in order to draw meaningful conclusions. Notably, few AD studies reported the loci
of group differences. Finally, some studies combined electrodes (i.e., ROI approach), but the number of
electrodes combined was much larger for late than for early components. Specifically, N200 and P300
ROIs typically included 3–4 electrodes (group averages = 3.0–4.1). In contrast, ROIs for N400 and LPC
included 2–7 times more electrodes (N400 group average ranged from 11 to 32; LPC group average
ranged from 13.2 to 14), making the source of these ROIs much less specific.

3.2. Event-related potential results

An overview of the general pattern of findings for all ERP components investigated by at least three
studies in this review are summarized in Table 5. The most common trends within each component are
summarized by diagnostic group to highlight patterns both within and across groups. Toward capturing
non-majority patterns that may impact future research, trends evident in the remainder of the studies
are also summarized within each ERP component and diagnostic group.

Table 5. Summarized ERP Findings and Trends in 100 Studies of MCI, AD, and Apolipoprotein-E (APOE) ε4 Included in the Review.

ERP
Compon
ent &
Metric

Mild
Cognitive
Impairment
N Studies

N200
Amplitu
de

18

Latency

19

P300
Amplitu
de

29

Latency

29

Alzheimer'
s Disease
Majority
Group
Differences

Minority/Notable
Group Differences

N Studies

Majority
Group
Differences

Minority/Nota
ble Group
Differences

None: 67 %
[11,22,28,5
1,53,78,81,
83,86,94,12
0,142]
None: 53 %
[28,29,51,7
8,81,83,86,
106,120,14
2]

MCI < HC: 22 %
[12,29,30,145]
(MCIa<MCIb,
HC [12]); MCI > HC:
11 % [106,107]
MCI > HC: 47 %
[11,12,22,30,53,90,9
4,107,145]; MCIa>M
CIb, HC [90]

11

None: 82 %
[31,60,63,69,7
3,92,110,118,
142]

AD < HC: 18 %
[84,145]

12

None: 55 %
[11,22,28,2
9,30,46,51,
78,94,105,1
06,107,114,
133,139,14
2]
None: 59 %
[22,23,28,2
9,30,46,57,
59,81,86,94
,105,107,11
4,120,133,1
39]

MCI < HC: 38 %
[12,23,53,57,59,81,8
3,86,138,145,148];
MCIa<MCIb,HC [12];
MCI > HC: 7 %
[82,120]
MCI > HC: 41 %
[11,12,50,51,53,78,8
3,106,138,142,145,1
48]; MCIa>MCIb,HC [
12]

Healthy/A
D Risk
(APOE ε4)
N Studies

Majority
Group
Differenc
es

Minority/N
otable
Group
Difference
s

4

None:
100 %
[39,54,93
,147]

–

None: 42 %
[31,60,69,84,1
42]

AD > HC: 42 %
4
[92,96,110,118,
135], trend 8 %
[145]; AD < HC:
8 % [63]

ε4+>ε4-:
100 %
[39,54,93
,147]

–

25

AD < HC: 56 %
[3,4,13,43,60,
63,71,84,89,1
14,118,142,14
5,152], trend 4
% [42]

None: 40 %
4
[31,47,69,72,73
,92,105,110,12
6,139]

None:
100 %
[39,54,93
,147]

–

30

AD > HC: 60 %
[3,43,60,63,71
,76,88,92,96,9
7,105,110,111
,118,135,139,
142,152],
trend 7 %
[52,145]

None: 27 %
[4,31,47,69,75,
84,114,126]; A
D < HC: 7 %
[13,72]

ε4+>ε4-:
60 %
[93,95,14
7]

None: 40
% [39,54]

5

N400
Amplitu
de

6

MCI < HC:
50 %
[1,48,64]

None: 33 %
[100,154]; MCI > HC:
17 % [137]

17

Latency

2

–

MCI > HC: 50 %
[100]; None: 50 %
[154]

9

3

MCI < HC:
67 %
[16,100]

MCI > HC LH, MCI <
HC RH [67]

6

–

None: 100 % [100]

None: 50 %
[48,64]
–

MCI < HC:
100 %
[16,116,146
]
–

Late
Positive
Compon
ent
(LPC)
Amplitu
de
Latency
Parietal
Effect
(PE)
Amplitu
de
Latency
Late
Positive
Potentia
l (LPP)
Amplitu
de
Latency

4

3

AD < HC: 65 %
[5,19,45,55,62
,68,99,103,12
3,129,150]
AD > HC: 56 %
[19,42,43,68,1
29], trend 11
% [99]

None: 24 %
[42,71,126,
137°]; AD > HC:
12 % [43,137°]
None: 33 %
[71,103,126]

1

–

–

–

ε4+>ε4- R
H, ε4+<ε4midline
[74]
–

–

–

–

–

–

AD < HC: 50 %
[45,99,123]; N
one: 50 %
[19,62,129]
–

None: 100 %
[19]

–

–

–

MCI < HC: 25 %
[154], trend 25 % [1]
–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

Slow
waves
(SW)
Amplitu
de

Latency

2

2

MCI > HC:
100 %
[30,131]; M
CIc>MCId,
HC [30]
MCI > HC:
100 %
[106,107]

–

–

–

–

–

–

–

–

–

–

–

–

–

–

Note: Only components analyzed in at least three studies are included; [text reference #]; MCI = Mild Cognitive Impairment;
AD = Alzheimer's disease; HC = older adults (controls); RH = right hemisphere; 1includes early frontal effect; °included twice (results differed
across comparisons); apMCI = progressing MCI; bnpMCi = non-progressing (stable) MCI; csdMC = single-domain (amnestic)
MCI; dmdaMCI = multi-domain amnestic MCI; None = no significant group effects; – = not investigated/reported.

3.2.1. N200
The N200 component is a negative-going wave that typically peaks within 100−300 ms post-stimulus
and can be broken down into two subcomponents: N200a (i.e., the mismatch negativity; MMN) and
N200b. N200a is thought to reflect automated sensory processing, specifically in response to novel
stimuli [109]. N200b tends to index conscious and intentional attention to stimuli, especially those that
deviate from the expected stimulus (e.g., oddball paradigms) [109]. Within inhibitory control
paradigms, N200b also reflects alerting to the need to activate inhibition preceding motor inhibition
[56,66]. While many studies investigating the N200 component did not separate N200a and N200b,
those that specifically isolated N200a (i.e., mismatch negativity) were excluded from the present
review due to the earlier, more automatic and sensory nature of this component [109,115].
Comprehensive reviews of the N200a subcomponent with age and AD have already been reported
[25,112]. A few studies assessed specific subcomponents of the N200 ERP including N2pc, N2cc, and
N250r [[20], [21], [22],26,36]. Given the limited research with these ERPs they are not discussed in the
review; see Table 1, Table 2 for individual study details in MCI and AD, respectively.
3.2.1.1. MCI amplitude

Eighteen studies assessed N200 amplitude in MCI compared to healthy controls, of which 12 reported
no significant group differences [i.e., 67 %; 11,22,28,51,53,78,81,83,86,94,120,142]. Of those that
detected significant group differences (i.e., 6/20 total studies), the majority reported smaller N200
amplitudes in MCI compared to HC [i.e., 67 % significant studies; 22 % total studies; 12,29,30,145]. One
further reported that N200 amplitudes were smallest in progressive MCI compared to non-progressive
MCI and healthy controls [12]. These studies primarily used more complex tasks than the traditional
oddball paradigm, including Go/No-Go and Flanker tasks (i.e., 3/4; 75 %). Of the 12 studies that did not
detect group differences, 50 % used simple visual or auditory oddball paradigms, suggesting that
differences in N200 amplitudes may not be sufficiently evident using simple oddball paradigms. The
remaining two studies, both from the same laboratory, in fact reported larger N200 amplitudes in the
MCI group [i.e., 11 %; 106,107]. One of these studies used particularly uneven sample sizes, with 91
MCI participants and 30 HC [106]. Notably, these MCI participants were at the young end of the range
for these studies and at the high end for MMSE. This may reflect early compensatory activation that
precedes decline [108,122].
3.2.1.2. AD amplitude

Eleven studies analyzed N200 amplitude differences between AD and HC, nine of which reported no
significant between-group differences [i.e., 82 %; 31,60,63,69,73,92,110,118,142]. All but one of these
studies employed auditory oddball tasks. In contrast, the two studies that reported significant
differences both used more complex executive function tasks; both demonstrated smaller N200
amplitudes in AD compared to HC groups [i.e., 18 %; 84,145]. Specifically, Wang et al. [145] used the
Erickson Flanker Task and Lockwood et al. [84] used an attentionally cued orientation discrimination
task. Both of these tasks tap inhibitory control and attention in a visual modality, thereby differing in
both modality and stimulus complexity from an auditory oddball paradigm.
3.2.1.3. Cognitively intact APOE ε4 carriers amplitude

Four of the six APOE studies investigated N200 amplitude; all four reported no significant differences
between ε4 carriers and non-carriers [39,54,93,147]. Yet, all studies used simple auditory oddball or
odor identification tasks, which as noted even with MCI and AD where cognitive symptoms are

present, may not be ideal for detecting AD-related differences in N200 amplitude. Furthermore, most
of these studies had small samples (e.g., nine per cell), indicating low power in detecting subtle group
differences in intact groups.
3.2.1.4. MCI latency

Ten of the 19 MCI studies assessing N200 latency reported no significant between-group differences
[i.e., 53 %; 28,29,51,78,81,83,86,106,120,142]. Of those that did detect significant differences, all nine
reported prolonged latencies in MCI compared to healthy control groups [i.e., 47
%; 11,12,22,30,53,90,94,107,145]. Missonier and colleagues further specified that N200 latencies were
prolonged in progressive MCI compared to both non-progressive MCI and healthy controls [90].
Several of the studies that reported non-significant results might have lacked sensitivity due to uneven
sample sizes and/or differences in average age between groups.
3.2.1.5. AD latency

Of the twelve studies that investigated N200 latency in AD, six reported prolonged N200 latencies in
the AD group (i.e., 50 %; five statistically significant, [i.e., 42 %; 92,96,110,118,135], one trending [i.e., 8
%; 145]). Five studies found no significant between-group differences [i.e., 42 %; 31,60,69,84,150],
though they had small samples, high AD MMSE scores (i.e., low impairment), and/or differences in age
between groups. Hirata and colleagues [63], in contrast to all other studies, reported
significantly shorter latencies in AD participants.
3.2.1.6. Cognitively intact APOE ε4 carriers latency

Four APOE studies examined group differences in N200 latency. Three reported significantly prolonged
N200 latency in ε4 carriers relative to non-carriers, including delayed N200 latencies in ε4+ compared
to ε4- within a sample with a positive family history of AD [54]. Two studies showed delayed N200
latencies in ε4+ groups with olfactory identification tasks, but not during visual or auditory oddball
paradigms. The remaining study demonstrated prolonged latency in ε4/ε4 (i.e., homozygotes; very
high risk) compared to ε4/ε3 (i.e., heterozygotes; high risk). Yet, ε4 homozygotes only differed from
low risk ε3/ε3 (i.e., ε4-) participants at a trend level [39]. The samples in all these studies were quite
small, precluding strong conclusions.
3.2.2. P300
The P300 component is a positive-going wave that peaks between 250−700 ms post-stimulus. As with
the N200 component, P300 is divided into P300a and P300b subcomponents. P300a generally occurs
within 250−280 ms, tends to have a fronto-central maxima, and is associated with novel stimulus
detection (i.e., infrequent perceptual stimuli in oddball paradigms), which may be modulated by
attentional demand [117]. P300b tends to peak around 250−500+ms with a parietal maxima, and is
associated with aspects of executive functioning, such as updating of working memory, subsequent
memory storage, inhibitory control, and selective attentional processes [4,109,117]. P300 has been the
frequent target of ERP studies, including in the limited literature on MCI and AD. The majority of the
studies assessing the P300 component in this review did not specify P300a vs. P300b. Thus, results and
interpretation could not be divided by subcomponent.
3.2.2.1. MCI amplitude

Sixteen of the 29 total studies assessing P300 amplitude in MCI reported no significant difference
between groups [i.e., 55 %; 11,22,[28], [29], [30],46,51,78,94,[105], [106], [107],114,133,139,142]. Of

the remaining 13 studies that reported group differences (i.e., 45 %), 11 reported smaller P300
amplitudes in MCI compared to HC groups [i.e., 85 % of significant studies; 38 % of total
studies; 12,23,53,57,59,81,83,86,138,145,148], including one that specified smaller amplitudes in
progressive MCI compared to both non-progressive MCI and healthy controls [12]. Of the studies that
detected group differences, 73 % used more complex executive functioning tasks (e.g., N-back, Go/Nogo). In contrast, 72 % of the studies that reported no group differences used oddball tasks, and two of
the studies that did report differences using oddball paradigms had particularly large sample sizes
[12,83]. The remaining two studies demonstrated larger P300 amplitudes in the MCI group [i.e., 7
%; 82,120], but both studies were unique in that they compared P300 condition/stimulus difference
waves instead of un-subtracted waveforms. These two studies specifically highlight abnormally
enhanced P300 amplitudes to less relevant stimuli (e.g., non-match vs. match) in MCI, in contrast to HC
who appropriately devoted more resources to processing novel and relevant stimuli [82,120]. These
two studies were therefore consistent with the other studies reporting MCI differences. Thus, at least
when more complex tasks were employed with reasonable statistical power, P300 amplitude
discriminated between groups, reflecting underlying neural deficits in MCI.
3.2.2.2. AD amplitude

The majority of the 25 studies that analyzed P300 amplitude reported smaller amplitude in AD
compared to HC groups [i.e., 60 %; 3,4,13,42,43,60,63,71,84,89,114,118,142,145,152], including one
reporting a trend that did not reach statistical significance [42]. The remaining ten studies reported no
significant difference between groups [i.e., 40 %; 31,47,69,72,73,92,105,110,126,139]. These latter AD
studies were notable for small sample sizes (e.g., eight per cell), age differences between groups, high
AD group MMSE scores (e.g., 27/30), and/or simple tasks (i.e., 67 % oddball paradigms), which may
have limited power to detect group differences.
3.2.2.3. Cognitively intact APOE ε4 carriers amplitude

Four studies assessed APOE group differences in P300 amplitude; none detected significant group
differences. It was, however, difficult to draw conclusions from these studies. Beyond their small
number, the use of small samples and simple tasks was common to all of them. Based on findings with
MCI and AD, they may not have had the sensitivity to detect subtle differences.
3.2.2.4. MCI latency

Of the 29 studies that assessed P300 latency in MCI, 17 reported no significant group differences [i.e.,
59 %; 22,23,[28], [29], [30],46,57,59,81,86,94,105,107,114,120,133,139]. All of the remaining studies
(i.e., 41 %) demonstrated delayed latency in MCI compared to HC groups
[11,12,50,51,53,78,83,106,138,142,145,148]. Bennys and colleagues [12] further specified that P300
latencies in the progressive MCI group were more delayed than those of the non-progressive MCI and
HC groups. Thus, P300 latency was more sensitive to neural differences in MCI than N200, even though
most studies showing such differences used simple tasks (75 % oddball tasks). However, it was notable
that sample sizes in these studies were amongst the largest (e.g., 34 participants per group), perhaps
allowing for greater sensitivity, even with a simple task.
3.2.2.5. AD latency

Thirty articles analyzed P300 latency in AD. The majority reported delayed latency in AD compared to
HC groups [i.e., 66 %; 3,43,52,60,63,71,76,88,92,96,97,105,110,111,118,135,139,142,145,152], two of

which reported non-significant trends [52,145]. No significant differences between groups were
detected in eight studies [i.e., 27 %; 4,31,47,69,75,84,114,126]. Two studies in fact reported shorter
P300 latency in AD compared to HC groups [i.e., 7 %; 13,72], although interpreting this in context of
other studies is difficult because one also reported high P300 variability in the AD group [13], and the
other used an atypically late window for the P300 component (i.e., 400−800 ms) [72].
3.2.2.6. Cognitively intact APOE ε4 carriers latency

Three of five APOE studies reported delayed P300 latencies in the ε4+ group when using an olfactory
identification task [i.e., 60 % of total studies; 93,95,147]. Notably, these same studies reported no
group differences when using visual or auditory oddball paradigms in the same participants. The two
remaining studies reported no significant differences [i.e., 40 %; 39,54], using oddball paradigms and
small samples (e.g., ten per cell).
3.2.3. N400
The N400 is a negative-going wave that peaks approximately 300−600 ms after stimulus onset and is
associated with the evaluation of meaningfulness, including semantic and language processing, and
recognition memory [77]. This component can be elicited with various task paradigms. For example,
N400 amplitude has an inverse relationship with semantic priming, in which novel stimuli tend to elicit
larger amplitudes than primed stimuli [i.e., priming effect; 5,77]. Similarly, incongruent stimuli tend to
elicit larger N400 amplitudes than congruent stimuli, a phenomenon often investigated by calculating
difference waves [i.e., N400 congruity effect; 77,102]. Furthermore, N400 amplitude tends to decrease
with repeated exposure to a stimulus [i.e., repetition effect; 102].
3.2.3.1. MCI amplitude

Three of six studies that assessed N400 amplitude in MCI groups reported smaller amplitudes in MCI
compared to healthy controls [i.e., 50 %; 1,48,64]. Two of these studies used recognition memory
paradigms [i.e., old/new effects; 1,64], while the third demonstrated a lack of visual object priming in
MCI [48]. All three of these studies specifically assessed N400 amplitude at frontal electrodes (i.e.,
frontal N400, FN400), which has been suggested to index familiarity and conceptual implicit memory
[32,80], with others suggesting no functional distinction between N400 components with frontal vs.
centro-parietal peaks [144]. A fourth study revealed larger N400 amplitudes in MCI vs. HC groups
during a priming task. As amplitude should decrease to primed stimuli, this study indicated semantic
priming deficits in the MCI group [i.e., 17 %; 137], consistent with the other studies showing deficits in
MCI vs. HC. The two final studies reported no significant group differences in N400 amplitude [i.e., 33
%; 100,154] using word repetition and face recognition tasks. Thus, although few studies are yet
available, N400 amplitude successfully differentiated between MCI and HC in 67 % of studies.
3.2.3.2. AD amplitude

The majority of AD studies showed smaller N400 amplitude in AD compared to HC groups across a
variety of metrics, including smaller raw waveforms, priming, congruity, and repetition effects [i.e., 65
%; 5,19,45,55,62,68,99,103,123,129,150]. Priming and repetition effects were the most frequently
used approach; of the 11 studies demonstrating AD < HC, seven (i.e., 64 %) used priming and/or
congruency paradigms. The remainder used repetition, categorization, or word fluency tasks (see Table
2). In contrast, two studies reported larger amplitudes in AD compared to HC groups [i.e., 12
%; 43,137]. Both were consistent with the other studies in showing priming deficits in AD. Ford and

colleagues [43] reported this in context of larger N400 amplitudes to both primed and unprimed words
in AD (typically primed < unprimed), while Taler et al. reported larger overall raw N400 amplitudes in
AD compared to HC during semantic priming, although no differences between groups were apparent
for semantic priming itself, and these samples were uneven in size and age distribution [137]. The final
three AD studies reported no significant group differences in N400 amplitude [i.e., 24
%; 42,71,126,137]. Two of these studies assessed N400 repetition effects using a word recognition task
with infrequent animal targets and had small sample sizes [71,126], while the other used picture-name
congruity [42]. Although there is some inconsistency in this small literature, particularly with different
tasks and methods of calculating N400 metrics, N400 amplitude nevertheless appears to differentiate
between AD and HC more consistently (76 %) than N200 (18 %) and P300 (60 %) amplitudes.
3.2.3.3. Cognitively intact APOE ε4 carriers

Only one study with healthy, cognitively intact APOE groups examined the N400 component [74].
Carriers of the APOE ε4 allele had greater N400 amplitude than non-carriers in the right hemisphere
during an odor-image congruency task, which is typically a left-hemisphere dominant task. Midline
N400 amplitudes, on the other hand, highlighted smaller amplitudes in the ε4+ compared to ε4- group.
Consistent with MCI and AD studies, N400 amplitude discriminated between APOE groups more
effectively than earlier (i.e., N200, P300) components.
3.2.3.4. MCI latency

Only two studies assessed N400 latency with MCI groups. One reported prolonged latency in MCI
compared to HC [100], while the other reported no significant group differences [154].
3.2.3.5. AD latency

The majority of the nine studies that analyzed N400 latency reported significantly delayed latencies in
AD groups compared to HC, including congruity effects, priming effects, and raw N400 latency [i.e., 66
%; 19,42,43,68,99,129], with one reporting a non-significant trend [99]. The three remaining studies
reported no significant difference between groups [i.e., 33 %; 71,103,126], though it should be noted
that each had very small samples (8–11 per cell). Notably, no studies to date have examined N400
latency in cognitively intact APOE ε4 carriers.
3.2.4. Late positive component, parietal effect, & late positive potential
The late positive component (LPC) is a positive-going wave that typically peaks around
500−800 ms post-stimulus. The LPC is thought to reflect memory encoding and retrieval, especially for
explicit recognition memory, and is often calculated as the difference between old and new trials (i.e.,
old/new effect). LPC also indexes semantic and syntactic processing, and may be investigated in a
repetition paradigm similar to the N400 component [101,104]. The parietal effect (also ∼500−800 ms)
is a recognition memory old/new effect (new > old) that is specifically largest over parietal electrodes
[149]. Relatedly, the late positive potential (LPP) falls under these same parameters (e.g., new > old
∼400−800 ms) but is particularly evident during emotive tasks [61].
3.2.4.1. MCI comparisons

Two of the three studies that investigated LPC amplitude reported smaller amplitudes in the MCI
compared to HC groups [i.e., 67 %; 16,100]. Both of these studies used repetition tasks, one an emotive
image repetition with a working memory component [16] and the other a word repetition task [100].
The remaining study also reported smaller amplitudes in MCI compared to HC in the right hemisphere,

but larger amplitudes in the left hemisphere during an olfactory oddball paradigm [i.e., 33 %; 67]. This
greater left hemisphere LPC magnitude was interpreted as a compensatory mechanism associated with
deficits in earlier, sensory-level processing. The only study that assessed LPC latency did not find
significant between-group differences [100]. With respect to the parietal effect in MCI, two of four
studies reported no significant group differences [i.e., 50 %; 48,64]. The other two reported smaller
parietal effects in MCI compared to HC groups, one at a significant level [154], and the other only
showing a non-significant trend [1]. Finally, all three studies that assessed the LPP component reported
significantly smaller LPP amplitudes in MCI compared to HC groups [16,116,146]. All three of these
studies are very recent (i.e., 2016–2018), suggesting the need for future research with this component.
3.2.4.2. AD comparisons

Of the six studies that investigated LPC amplitude in AD, three reported smaller amplitudes in AD
groups compared to HC [i.e., 50 %; 45,99,123], while the other three reported no significant group
differences [i.e., 50 %; 19,62,129]. Only one study thus far analyzed LPC latency, reporting no
significant group differences [19]. There were no studies specific to the parietal effect or late positive
potential with AD groups or any of these components in cognitively intact elders stratified by APOE ε4.
3.2.5. Slow waves
Slow wave ERPs follow the P300 component and are characterized by their slow onset, resembling
plateaus rather than peaks. The specific role of slow wave potentials is still debated, but they are
thought to generally reflect ongoing higher-order processing of stimuli [125]. No studies have been
reported examining AD or ε4 compared with controls, but four studies exist in MCI, which examined
positive- and negative-slow waves during Go/No-go, auditory oddball, and task switching. Both studies
that assessed slow wave amplitude reported larger amplitude in MCI compared to HC groups, including
greater amplitude in single domain MCI compared to both multiple domain MCI and controls [30,131].
Furthermore, both studies of slow wave latency highlighted prolonged latency in MCI compared to HC
[106,107].

4. Discussion

Overall, the literature examining cognitive ERPs in MCI, AD, or risk for AD (APOE ε4) relative to HC is
quite small. The 100 studies meeting criteria for this review predominantly covered N200, P300 and
N400, but they did so with mostly small samples and a wide range of approaches and sample
characteristics. Yet, there is some consistency in findings across studies that lends confidence in the
importance of cognitive ERPs toward assessment and early predictions of cognitive decline, as well as
in directing future research. Here we endeavor to highlight those consistencies and directions.

4.1. N200

Given the frequency of oddball paradigms in the reviewed studies, the N200 component as we have
covered it herein tends to index conscious, intentional attention to stimuli, especially to deviations
from an expected stimulus [109]. Since attentional deficits are often evident in early stages of AD and
may contribute to decline in other higher order cognitive processes, such as memory and planning
[8,124], N200 is a candidate component to be sensitive to relatively subtle neural changes associated
with AD. Despite this possibility, the majority of N200 amplitude studies detected no significant group
differences (ε4: 100 %; MCI: 67 %; AD: 82 %; see Table 5). However, conclusions from these studies are

limited by an almost universal use of small, unbalanced samples (e.g., cells often ≤ 10) and simple,
even passive, oddball paradigms. Indeed, during lesser-used higher-order cognitive tasks, such as
executive attention or inhibitory control, or visual modality rather than auditory, N200 amplitude was
significantly reduced in MCI and AD relative to HC. N200 in the context of executive functioning tasks
may reflect conflict monitoring and pre-motoric alerting of the need to activate inhibitory control
processes [56,66]. More research is needed to better understand the underlying processes associated
with the N200 component with higher-order cognitive processes and to assess the discriminative
ability of N200 in this context.
N200 latency discriminated between groups in approximately half of the studies (ε4: 100 %; MCI: 47 %;
AD: 50 %; see Table 5), despite the task and sample size limitations. Indeed, even in cognitively intact
elders at risk for AD by carrying the APOE ε4 allele, prolonged N200 latency was apparent in all four
studies regardless of task type and small samples. Moreover, follow-up testing in one of these studies
demonstrated that N200 latency predicted verbal learning decline 3.5 years later [39]. Future
investigation of the N200 component, particularly with visual or complex executive and attentional
tasks, is important toward confirming whether the N200 is a robust index of early neural changes
associated with pathological aging.

4.2. P300

The P300 component, which is associated with detection of novel stimuli, updating of working
memory, inhibitory control, and selective attentional processes [109], may be sensitive to AD-related
changes as deficits in working memory and attention are common in AD [7,10,49,132]. As such, P300
has been the most studied ERP component in this context. We note that despite different sources and
cognitive processes associated with P300a vs. P300b, we were precluded from interpreting these
distinctions because few of the studies specified P300 subcomponents. Thus, distinguishing these
subcomponents is an important future direction.
Our review highlighted a diagnostic severity-indexed trend across studies of reduced P300 amplitude
(ε4: 0 %; MCI: 38 %; AD: 60 %; see Table 5) and prolonged latency (ε4: 60 %; MCI: 41 %; AD: 66 %;
see Table 5). P300 amplitude differences were best highlighted by executive function tasks, while P300
latency uniquely differentiated groups even during oddball paradigms when using larger samples. Thus,
P300 latency was more robust to these group differences than N200 latency in oddball tasks. Indeed,
one P300 auditory oddball study further distinguished groups by severity of AD showing P300
amplitude was reduced late, in the moderate AD stage, while P300 latency was progressively delayed
coincident with level of cognitive impairment, and evident earlier in the disease course than amplitude
differences [60]. Although the literature in cognitively intact elders carrying APOE ε4 is very small with
P300 (five studies), an olfactory identification task showed prolonged P300 latency in ε4+ that oddball
tasks did not reveal. Olfactory tasks may be robust to group differences at various stages, though this
modality requires specially built olfactometers and careful control over the sensory environment,
which may limit their broad use.
Despite the relatively consistent pattern of reduced P300 amplitude and delayed P300 latency in wellpowered AD studies, this pattern nevertheless was representative of only about 60–65 % of the
available studies. As such, conclusions about the sensitivity of P300 to early AD pathology should be
made with caution. Notably, one study using a Stroop color-word interference task found delayed P300

latency in a middle-aged MCI group compared to middle-aged HC, with 0.9 sensitivity and specificity to
distinguish the groups, suggesting that complex attention or executive tasks may be best able to
characterize neural changes evident early in the course of neuropathology [120]. Thus, future research,
particularly with complex attention and executive tasks assessing group differences in P300 amplitude,
will be key to determining the value of P300 to early stage disease differences (e.g., APOE ε4 AD risk,
MCI).

4.3. N400

The N400 component is associated with the evaluation of meaningfulness, including semantic and
language processing, and recognition memory [77]. Deficits in multiple domains of semantic and
language processing are core features of AD progression [127,143]. Indeed, although episodic memory
deficit is a hallmark of AD, semantic memory impairment is estimated to affect at least 50–82 % of
those with AD [143]. While less commonly investigated, there is also evidence of semantic deficits in
MCI [38,70]. Thus, the N400 may be an important candidate for indexing early neural changes
associated with AD. Consistent with this contention, N400 amplitude most consistently differentiated
MCI (67 %) and AD (76 %) from HC groups across the components we reviewed (see Table 5).
Amplitudes were generally smaller in MCI and AD compared to HC using raw waveforms, priming,
congruity, and repetition effects, accompanied by evidence of reduced or absent priming and
repetition effects in MCI and AD. These consistent patterns across various approaches highlight the
disruption of semantic networks evident with AD pathology. Furthermore, MCI studies particularly
highlighted the importance of the frontal N400 [i.e., FN400, early frontal effect; 144], which is thought
to index familiarity and arguably identical in source to the traditional N400 [but also see 15].
Importantly, during recognition memory paradigms, it both distinguished MCI from HC group and
correlated with episodic memory performance and medial temporal lobe gray matter volume [64].
Despite these promising findings, research with the N400 is lacking, particularly in MCI, compared with
other components; only 6 MCI studies exist (see Tables 1 & 5). Even less well studied is N400 latency,
despite the generally strong indication that it is prolonged in AD (67 %; see Table 5). Moreover, only
one study analyzed N400 amplitude with cognitively intact APOE ε4 carriers, revealing right
hemisphere recruitment during a left hemisphere task, thereby suggesting a compensatory function
[18,108,122]. This was the only available study of AD risk groups that examined a later cognitive ERP
component or used a more complex cognitive task. Indeed, it was also the only study to reveal
significant differences in ERP amplitude between cognitively intact AD risk groups, despite having only
ten participants per group. Thus, the N400 component demonstrates promise for distinguishing
between healthy and pathological aging. Future N400 research using complex cognitive tasks with MCI,
AD, and healthy AD risk groups is critical to improve understanding of early changes that presage
cognitive decline.

4.4. Other late components and non-traditional approaches

While little investigated, other later components reflective of recognition memory show promise for
discriminating MCI (LPC, PE, and LPP) and AD (LPC) from healthy control groups, generally showing
reduced amplitude in MCI and AD (see Table 5). No studies have yet investigated latency for these
components between these groups. Similarly, slow waves, which may reflect cognitive processes such
as memory or emotion processing depending on the context, have been little studied in MCI and AD,

but the two existing studies showed smaller amplitude and delayed latency in MCI relative to HC across
both low-level and complex tasks (see Table 5). Future research on these components is particularly
important given promising results in so few studies that varied greatly in task and study characteristics.
As noted based on components that have received more study than these, additional studies using
complex tasks might be particularly effective at discriminating between groups, perhaps especially at
an early stage preceding measurable cognitive impairment.

4.5. Conclusions and future directions

The existing literature in MCI, AD, and APOE ε4 risk for AD suggests more research is warranted
investigating cognitive ERPs as potential biomarkers of AD-related neuropathology. The studies
reviewed highlight overall patterns of reduced amplitude and delayed latency in pathological aging
(MCI, AD) compared to healthy controls, particularly in advanced disease progression and when
examining later ERP components with relatively complex cognitive tasks. Such patterns are particularly
evident in AD, where reduced P300 and N400 amplitude and prolonged N200, P300, and N400 latency
were common findings. Similar but less robust patterns were evident in MCI. Strikingly, only six studies
examining cognitively intact participants with risk for AD met inclusion criteria for this review, four of
which used olfactory ERPs. They typically showed prolonged ERP latencies in ε4 carriers relative to noncarriers, while only one differentiated ERP amplitude by AD risk; using a late component (N400) and a
complex task with relevant lateral electrodes, increased right hemisphere amplitude suggested
compensatory activation in ε4 carriers [74]. This finding was consistent with recent fMRI research
showing initially greater neural activation in cognitively intact older adults who carry the APOE ε4 allele
[14,121,151], which reverses over time in ε4 carriers who exhibit cognitive decline, compared with a
steady increase in activation in non-carriers [121].
Our review also highlighted the gaps in this scant literature, including the small number of existing
studies, small samples, vastly varying paradigms and analytical methods, lack of subcomponent
differentiation and lateral electrode analysis, and variability in age and cognitive functioning in
comparison groups. Indeed, such differences, and an overall paucity of reporting of key contrast data
or effect sizes substantively deter meaningful and reproducible meta-analyses within and across
components. Yet, these limitations did not preclude the ability to see overall patterns hinting at
promise for ERPs as a feasible approach to an early index of AD. Future studies that specifically
examine later cognitive ERP components in AD, MCI and cognitively intact AD-risk with larger,
comparable groups and preferably complex cognitive tasks are urgently needed to evaluate that
promise. Future research must also aim to establish the sensitivity and specificity of ERPs in
differentiating between groups. This would allow determination of whether ERPs could be useful in
combination with neuropsychological testing toward identification, prediction, and tracking of neural
changes prior to and coinciding with cognitive decline, thereby assisting with targeting for intervention.
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